Pyxis Oncology prices public offering up to $282.6 million
Pyxis Oncology priced its registered public offering of 36.05 million common shares and pre-funded warrants, aiming for up to $282.6 million in proceeds.
Pyxis Oncology priced its registered public offering of 36.05 million common shares and pre-funded warrants, aiming for up to $282.6 million in proceeds.